Félix López Cadenas

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

Nerea Berastegui, Marina Ainciburu, Juan P. Romero et al. · Nature Communications · 2022 · 25 citations · Full text

Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia

Marta Martín‐Izquierdo, María Abáigar, Jesús María Hernández-Sánchez et al. · Haematologica · 2020 · 20 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Genetics +17

Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors

Alejandro Olivares-Hernández, Luis Figuero-Pérez, María Antonieta Martin et al. · Case Reports in Oncological Medicine · 2021 · 20 citations · Full text

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes

Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Blood · 2021 · 19 citations

Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multicenter Clinical Trial

Félix López Cadenas, Eva Lumbreras, Teresa González et al. · Blood · 2022 · 18 citations